Over 141 Acres of Land Allocated for Pharma Park in Naya Raipur
ECONOMY & POLICY

Over 141 Acres of Land Allocated for Pharma Park in Naya Raipur

Chhattisgarh is positioning itself as a key pharmaceutical hub in central India, with the Naya Raipur Atal Nagar Development Authority allocating 141.84 acres of land in Sector-22 for the establishment of a pharmaceutical park. The Chhattisgarh State Industrial Development Corporation (CSIDC) has been granted the land to develop this initiative.

According to state representatives, the development of this park is part of a broader strategy to strengthen healthcare services and improve accessibility for citizens. The project aligns with the state’s new industrial policy for 2024-30, which offers various incentives and concessions to pharmaceutical industries.

The government anticipates that the pharmaceutical park will attract both domestic and international investments, increase competition in the sector, create jobs for local youth, and stimulate economic growth in the state.

"Through this park, we aim to meet the growing demand for healthcare products both domestically and internationally. Additionally, Chhattisgarh’s Shaheed Veer Narayan Singh Ayushman Health Scheme provides free treatment to 77.20 lakh families in the state, which will be expanded to cover Rs 10 lakh in the future," said the government spokesperson.

The facility will support pharmaceutical units specialising in Ayush products, with modern infrastructure including a flatted factory complex and a common effluent treatment plant (CETP). The park will also feature research and development centres and testing laboratories.

The state government offers a 100% investment promotion on capital investments for large-scale pharmaceutical enterprises, including reimbursements for SGST payments and capital investment grants.

Chhattisgarh is positioning itself as a key pharmaceutical hub in central India, with the Naya Raipur Atal Nagar Development Authority allocating 141.84 acres of land in Sector-22 for the establishment of a pharmaceutical park. The Chhattisgarh State Industrial Development Corporation (CSIDC) has been granted the land to develop this initiative. According to state representatives, the development of this park is part of a broader strategy to strengthen healthcare services and improve accessibility for citizens. The project aligns with the state’s new industrial policy for 2024-30, which offers various incentives and concessions to pharmaceutical industries. The government anticipates that the pharmaceutical park will attract both domestic and international investments, increase competition in the sector, create jobs for local youth, and stimulate economic growth in the state. Through this park, we aim to meet the growing demand for healthcare products both domestically and internationally. Additionally, Chhattisgarh’s Shaheed Veer Narayan Singh Ayushman Health Scheme provides free treatment to 77.20 lakh families in the state, which will be expanded to cover Rs 10 lakh in the future, said the government spokesperson. The facility will support pharmaceutical units specialising in Ayush products, with modern infrastructure including a flatted factory complex and a common effluent treatment plant (CETP). The park will also feature research and development centres and testing laboratories. The state government offers a 100% investment promotion on capital investments for large-scale pharmaceutical enterprises, including reimbursements for SGST payments and capital investment grants.

Next Story
Infrastructure Urban

Reliance, Diehl Advance Pact for Precision-Guided Munitions

Diehl Defence CEO Helmut Rauch and Reliance Group’s Founder Chairman Anil D. Ambani have held discussions to advance their ongoing strategic partnership focused on Guided and Terminally Guided Munitions (TGM), under a cooperation agreement originally signed in 2019.This collaboration underscores Diehl Defence’s long-term commitment to the Indian market and its support for the Indian Government’s Make in India initiative. The partnership’s current emphasis is on the urgent supply of the Vulcano 155mm Precision Guided Munition system to the Indian Armed Forces.Simultaneously, the “Vulc..

Next Story
Infrastructure Urban

Modis Navnirman to Migrate to Main Board, Merge Subsidiary

Modis Navnirman Limited has announced that its Board of Directors has approved a key strategic initiative involving migration from the BSE SME platform to the Main Board of both BSE and NSE, alongside a merger with its wholly owned subsidiary, Shree Modis Navnirman Private Limited.The move to the main boards marks a major milestone in the company’s growth trajectory, reflecting its consistent financial performance, robust corporate governance, and long-term commitment to value creation. This transition will grant the company access to a broader investor base, improve market participation, en..

Next Story
Infrastructure Urban

Global Capital Flows Remain Subdued, EMEA Leads in Q1 2025

The Bharat InvITs Association’s industry update for Q1 2025 shows subdued global capital flows, with investment volumes remaining at the lower end of the five-year range despite a late 2024 recovery. According to data from Colliers and MSCI Real Capital Analytics, activity in North America declined slightly, while EMEA maintained steady levels and emerged as the top region for investment in standing assets.The EMEA region now hosts seven of the top ten cross-border capital destinations for standing assets, pushing the United States’ share of global activity below 15 per cent. Meanwhile, in..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?